PANews reported on October 9th that according to PR Newswire, Leap Therapeutics (NASDAQ: LPTX), a biotechnology company, announced that it has completed its previously announced private placement led by Winklevoss Capital, raising $58,888,888 in cash to launch its digital asset finance strategy. Winklevoss Capital will provide financial and strategic support to help Leap build and execute its digital asset finance strategy.


